Advertisement

Psoriatic Arthropathy

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

Psoriatic arthritis (PsA) presents as a diverse group of arthritis ranging from peripheral monoarticular and polyarticular disease to axial skeletal involvement. PsA in the elderly shows some differences from the young-onset disease. They have a higher involvement of active joints, foot erosions and elevation of CRP and synovial IL-1 beta and IL-beta, and the progression rate is higher than in the younger group. About 40% of patients with PsA show the presence of spondylitis. PsA also confers a significant increase in mortality risk, and the major causes of death among patients with psoriasis include myocardial infarction, respiratory causes and cancer. PsA patients have reduced quality of life and functional capacity compared to psoriasis patients.

Keywords

Psoriatic arthritis Psoriasis Quality of life Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) 

References

  1. 1.
    Diez-Porres L, Munoz-Fernandez S, Aguado P, Alonso M, Martin-Mola E. Remitting seronegative symmetrical synovitis with pitting oedema as the first presentation of psoriatic arthropathy. Rheumatology. 2002;41:1333–1335.CrossRefPubMedGoogle Scholar
  2. 2.
    Gladman DD. Psoriatic arthritis. Rheum Dis Clin North Am. 1998;24:825–44.CrossRefGoogle Scholar
  3. 3.
    Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Dermatol. 2003;4:441–7.CrossRefGoogle Scholar
  4. 4.
    Lopez-Montilla MD, Gonzalez J, Marinez FG, Fernandez-Moreno JR, Collantes E. Clinical features of late -onset psoriatic arthritis. Exp Gerontol. 2002;37(2–3):441–3.CrossRefPubMedGoogle Scholar
  5. 5.
    Punzi L, Pianon M, Rossini P, Schiavon F, Gambani PF. Clinical and laboratory manifestations of elderly onset psoriatic arthritis.: comparison with younger onset disease. Ann Rheum Dis. 1999;58(4):226–229.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kahn MA, van der Linden SM: A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum. 1990;20:107–43.CrossRefGoogle Scholar
  7. 7.
    Olivieri L, Van Tubergen A, Salvarani C, van der Linden S. Seronegative spondyloarthritides. Best Pract Recs Clin Rheumatol. 2002;16:723–39.CrossRefGoogle Scholar
  8. 8.
    Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features course and outcome. Ann Rheum Dis. 2005;64:ii14–ii17.  https://doi.org/10.1136/ard.2004.032482.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Castellino M, Baryon A. Genetic susceptibility factors for psoriatic arthritis. Curr Opin Rheumatol. 2010 ;22:152–156.CrossRefGoogle Scholar
  10. 10.
    Gladman DD, Cheung C, Ng CM,Wade JA. HI A-C locus alleles in patients with psoriatic arthritis (PsA). Hum Immunol. 1999; 0:259–61.CrossRefGoogle Scholar
  11. 11.
    Queiro R, Tejon P, Alonso S, Coto P. Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology 9 2013  https://doi.org/10.1093/rheumatology/ket363.
  12. 12.
    Moll JMH, Wright V. Psoriatic arthritis: a review. Semin Arthritis Rheumatol. 1973; 3: 55–78.CrossRefGoogle Scholar
  13. 13.
    Lee S, Mendelsohn A, Sarneo E. The burden of psoriatic arthritis: a literature review from a global health system perspective. Pharma Ther. 2010;35:680–689.Google Scholar
  14. 14.
    Cantini F, Niccoli I, Nannini C, Kalondi O, Bertoi M, Cassara E. Psoriatic arthritis: a systematic review. Int J Rheum Dis. 2010;13:300–317.CrossRefPubMedGoogle Scholar
  15. 15.
    Salam A, Henry R, Sheeran T. Acute onset psoriatic arthritis in older people.: Is it RS3PE?. Cases J. 2008;1:132.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Russel EB, Hunter JB, Pearson L, McCarty DT. Remitting sero-negative symmetrical synovitis with pitting edema − 13 additional cases. J Rheumatol. 1990;17:663–9.Google Scholar
  17. 17.
    Yosipovitch G,Tang MBY. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs & Aging. 2002;15:847–863.CrossRefGoogle Scholar
  18. 18.
    Saad AA, Symmons DP, Noyce PR, Ascroft DM. Risks and benefits of tumour necrosis factor-alpha inhibitors and the management of psoriatic arthritis: Systematic review and meta-analysis of randomized controlled trials. J Rheumatol. 2008;35(5):583–90.Google Scholar
  19. 19.
    Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehacke WH, et al. Treatment recommendations of psoriatic arthritis. Ann Rheum Dis 2009;69:1387–1394.CrossRefGoogle Scholar
  20. 20.
    Mease PJ. Psoriatic arthritis therapy advances-spondyloarthropathies. Curt opin Rheumat. 2005;17(4):426–432 .CrossRefGoogle Scholar
  21. 21.
    Hammadi AA. Psoriatic arthritis. http://emedicine.medscape.com/arthritis/2196539-overview retrieved 9 March 2015.
  22. 22.
    Taylor WJ. Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning Health and Disability. Curr Rheumatol Rep. 2012;14(4):369–74.CrossRefPubMedGoogle Scholar
  23. 23.
    Chang CA, Gottlieb AB, Lizzul PF. Management of psoriatic arthritis from the view of the dermatologist: Long term consequences of PsA. Medscape. http://www.medscape.org/viewarticle/749147_3 accessed on 3 September 2015.
  24. 24.
    Gladman DD. The natural history of psoriatic arthritis. Wright V, Helliwell PS. Psoriatic arthritis in Bailliere’s Clinical Rheumatology. International Practice and Research. London: Bailliere Tindall, 1994:379–94.Google Scholar
  25. 25.
    Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mork C, et al. Quality of life and the prevalence of arthritis reported by 5795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol. 2002;82:108–13.CrossRefPubMedGoogle Scholar
  26. 26.
    Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emmanuel EJ. Quantifying the harmful effects of psoriasis on health related quality of life. J Am Acad Dermatol. 2002;47(4);61286*8.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations